Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 35 entries
Sorted by: Best Match Show Resources per page
Changing the Assessment Paradigm: Promoting a Growth Mindset Across the Medical Education Continuum

Growth Mindset

Snydman LK.
GSID: EOK28EhWXkEJ
A Puri, M Memari, EM Sottile, LK Snydman… - The American Journal of …, 2023 - Elsevier

… fixed mindset assumes that intelligence and ability are static, and success is the affirmation of inherent intelligence. In contrast, a growth mindset … Growth mindset does not just focus on …

Cite
Puri, A., Memari, M., Sottile, E. M., Snydman, L. K., Lee, W. W., Bonnema, R. A., ... & Nandiwada, D. R. (2023). Changing the Assessment Paradigm: Promoting a Growth Mindset Across the Medical Education Continuum. The American Journal of Medicine, 136(2), 207-212.
Puri, Aditi, et al. "Changing the Assessment Paradigm: Promoting a Growth Mindset Across the Medical Education Continuum." The American Journal of Medicine 136.2 (2023): 207-212.
Copy Download .nbib Format: MLA
Representation, Belongingness, and Rumination in Underrepresented Psychology Students

STEM and underrepresented

Rice L, Snidman HR.
GSID: lmQRgikZIbAJ
HR Snidman, L Rice, K Sparger - Teaching of Psychology, 2022 - journals.sagepub.com

Background Research examining STEM fields has identified barriers for traditionally marginalized groups pursuing these fields including a lack of representation and adequate role models. Objective Grounded with Minority Stress Theory (MST), the current study examines if a lack of...

Cite
Snidman, H. R., Rice, L., & Sparger, K. (2022). Representation, Belongingness, and Rumination in Underrepresented Psychology Students. Teaching of Psychology, 00986283221095115.
Snidman, Hannah R., Lindsay Rice, and Kade Sparger. "Representation, Belongingness, and Rumination in Underrepresented Psychology Students." Teaching of Psychology (2022): 00986283221095115.
Copy Download .nbib Format: MLA
Effects of pretreatment with dexfenfluramine and fluoxetine on metoclopramide-induced aldosterone secretion in healthy volunteers.

Clinical drug investigation

Sommers de K, Snyman JR, van Wyk M.
PMID: 18370554
Clin Drug Investig. 1998;16(4):329-33. doi: 10.2165/00044011-199816040-00007.

OBJECTIVE: The present placebo-controlled study was designed to compare the effect of acute pretreatment with dexfenfluramine and fluoxetine on the plasma aldosterone response to metoclopramide. STUDY PARTICIPANTS AND DESIGN: Ten healthy ambulatory male volunteers participated. Following a single-blind, randomised...

Cite
Sommers de K, Snyman JR, van Wyk M. Effects of pretreatment with dexfenfluramine and fluoxetine on metoclopramide-induced aldosterone secretion in healthy volunteers. Clin Drug Investig. 1998;16(4):329-33doi: 10.2165/00044011-199816040-00007.
Sommers, d. e. . K., Snyman, J. R., & van Wyk, M. (1998). Effects of pretreatment with dexfenfluramine and fluoxetine on metoclopramide-induced aldosterone secretion in healthy volunteers. Clinical drug investigation, 16(4), 329-33. https://doi.org/10.2165/00044011-199816040-00007
Sommers, de K, et al. "Effects of pretreatment with dexfenfluramine and fluoxetine on metoclopramide-induced aldosterone secretion in healthy volunteers." Clinical drug investigation vol. 16,4 (1998): 329-33. doi: https://doi.org/10.2165/00044011-199816040-00007
Sommers de K, Snyman JR, van Wyk M. Effects of pretreatment with dexfenfluramine and fluoxetine on metoclopramide-induced aldosterone secretion in healthy volunteers. Clin Drug Investig. 1998;16(4):329-33. doi: 10.2165/00044011-199816040-00007. PMID: 18370554.
Copy Download .nbib Format: NLM
Antiviral immunotherapy: a review of current status.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

DesJardin JA, Snydman DR.
PMID: 18020581
BioDrugs. 1998 Jun;9(6):487-507. doi: 10.2165/00063030-199809060-00006.

Unselected intramuscular (IM) and intravenous (IV) immunoglobulins, as well as virus-specific hyperimmune globulins, occupy important roles as immunotherapy for viral infections. Standard IM immunoglobulins may be utilised in selected, susceptible patients for the prevention of hepatitis A and measles....

Cite
DesJardin JA, Snydman DR. Antiviral immunotherapy: a review of current status. BioDrugs. 1998;9(6):487-507doi: 10.2165/00063030-199809060-00006.
DesJardin, J. A., & Snydman, D. R. (1998). Antiviral immunotherapy: a review of current status. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy, 9(6), 487-507. https://doi.org/10.2165/00063030-199809060-00006
DesJardin, J A, and Snydman, D R. "Antiviral immunotherapy: a review of current status." BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy vol. 9,6 (1998): 487-507. doi: https://doi.org/10.2165/00063030-199809060-00006
DesJardin JA, Snydman DR. Antiviral immunotherapy: a review of current status. BioDrugs. 1998 Jun;9(6):487-507. doi: 10.2165/00063030-199809060-00006. PMID: 18020581.
Copy Download .nbib Format: NLM
Phase 1 clinical study of the acute and subacute safety and proof-of-concept efficacy of carbohydrate-derived fulvic acid.

Clinical pharmacology : advances and applications

Gandy JJ, Meeding JP, Snyman JR, van Rensburg CE.
PMID: 22427734
Clin Pharmacol. 2012;4:7-11. doi: 10.2147/CPAA.S25784. Epub 2012 Feb 17.

BACKGROUND: The purpose of this research was to determine the acute and subacute safety and proof-of-concept efficacy of carbohydrate-derived fulvic acid (CHD-FA).METHODS: In this double-blind study, 30 male volunteers with predetermined atopy were randomly assigned to either Group A...

Cite
Gandy JJ, Meeding JP, Snyman JR, et al. Phase 1 clinical study of the acute and subacute safety and proof-of-concept efficacy of carbohydrate-derived fulvic acid. Clin Pharmacol. 2012;4:7-11doi: 10.2147/CPAA.S25784.
Gandy, J. J., Meeding, J. P., Snyman, J. R., & van Rensburg, C. E. (2012). Phase 1 clinical study of the acute and subacute safety and proof-of-concept efficacy of carbohydrate-derived fulvic acid. Clinical pharmacology : advances and applications, 47-11. https://doi.org/10.2147/CPAA.S25784
Gandy, Justin John, et al. "Phase 1 clinical study of the acute and subacute safety and proof-of-concept efficacy of carbohydrate-derived fulvic acid." Clinical pharmacology : advances and applications vol. 4 (2012): 7-11. doi: https://doi.org/10.2147/CPAA.S25784
Gandy JJ, Meeding JP, Snyman JR, van Rensburg CE. Phase 1 clinical study of the acute and subacute safety and proof-of-concept efficacy of carbohydrate-derived fulvic acid. Clin Pharmacol. 2012;4:7-11. doi: 10.2147/CPAA.S25784. Epub 2012 Feb 17. PMID: 22427734; PMCID: PMC3304339.
Copy Download .nbib Format: NLM
Feedback based on observation of work rounds improves residents' self-reported teaching skills.

Journal of graduate medical education

Chandler D, Snydman LK, Rencic J.
PMID: 23997886
J Grad Med Educ. 2012 Sep;4(3):374-7. doi: 10.4300/JGME-D-11-00206.1.

INTRODUCTION: Residents provide a significant amount of bedside teaching to medical students and more junior colleagues, but often do not receive feedback that is tailored to this aspect of their professional performance.OBJECTIVE: To assess residents' self-reported improvement in teaching...

Cite
Chandler D, Snydman LK, Rencic J. Feedback based on observation of work rounds improves residents' self-reported teaching skills. J Grad Med Educ. 2012;4(3):374-7doi: 10.4300/JGME-D-11-00206.1.
Chandler, D., Snydman, L. K., & Rencic, J. (2012). Feedback based on observation of work rounds improves residents' self-reported teaching skills. Journal of graduate medical education, 4(3), 374-7. https://doi.org/10.4300/JGME-D-11-00206.1
Chandler, Daniel, et al. "Feedback based on observation of work rounds improves residents' self-reported teaching skills." Journal of graduate medical education vol. 4,3 (2012): 374-7. doi: https://doi.org/10.4300/JGME-D-11-00206.1
Chandler D, Snydman LK, Rencic J. Feedback based on observation of work rounds improves residents' self-reported teaching skills. J Grad Med Educ. 2012 Sep;4(3):374-7. doi: 10.4300/JGME-D-11-00206.1. PMID: 23997886; PMCID: PMC3444195.
Copy Download .nbib Format: NLM
A systematic review of the use and effectiveness of the Objective Structured Teaching Encounter.

Medical teacher

Trowbridge RL, Snydman LK, Skolfield J, Hafler J, Bing-You RG.
PMID: 22022900
Med Teach. 2011;33(11):893-903. doi: 10.3109/0142159X.2011.577463.

BACKGROUND: The Objective Structured Teaching Encounter (OSTE) has been proposed as a means of promoting and assessing the teaching skills of medical faculty.AIMS: To describe the uses of the OSTE and the evidence supporting its effectiveness.METHOD: MEDLINE (January 1966...

Cite
Trowbridge RL, Snydman LK, Skolfield J, et al. A systematic review of the use and effectiveness of the Objective Structured Teaching Encounter. Med Teach. 2011;33(11):893-903doi: 10.3109/0142159X.2011.577463.
Trowbridge, R. L., Snydman, L. K., Skolfield, J., Hafler, J., & Bing-You, R. G. (2011). A systematic review of the use and effectiveness of the Objective Structured Teaching Encounter. Medical teacher, 33(11), 893-903. https://doi.org/10.3109/0142159X.2011.577463
Trowbridge, Robert L, et al. "A systematic review of the use and effectiveness of the Objective Structured Teaching Encounter." Medical teacher vol. 33,11 (2011): 893-903. doi: https://doi.org/10.3109/0142159X.2011.577463
Trowbridge RL, Snydman LK, Skolfield J, Hafler J, Bing-You RG. A systematic review of the use and effectiveness of the Objective Structured Teaching Encounter. Med Teach. 2011;33(11):893-903. doi: 10.3109/0142159X.2011.577463. PMID: 22022900.
Copy Download .nbib Format: NLM
A prospective, observational study comparing the PK/PD relationships of generic Meropenem (Mercide.

Clinical pharmacology : advances and applications

Mer M, Snyman JR, van Rensburg CE, van Tonder JJ, Laurens I.
PMID: 27895516
Clin Pharmacol. 2016 Nov 17;8:191-198. doi: 10.2147/CPAA.S106676. eCollection 2016.

INTRODUCTION: Clinicians' skepticism, fueled by evidence of inferiority of some multisource generic antimicrobial products, results in the underutilization of more cost-effective generics, especially in critically ill patients. The aim of this observational study was to demonstrate equivalence between the...

Cite
Mer M, Snyman JR, van Rensburg CE, et al. A prospective, observational study comparing the PK/PD relationships of generic Meropenem (Mercide. Clin Pharmacol. 2016;8:191-198doi: 10.2147/CPAA.S106676.
Mer, M., Snyman, J. R., van Rensburg, C. E., van Tonder, J. J., & Laurens, I. (2016). A prospective, observational study comparing the PK/PD relationships of generic Meropenem (Mercide. Clinical pharmacology : advances and applications, 8191-198. https://doi.org/10.2147/CPAA.S106676
Mer, Mervyn, et al. "A prospective, observational study comparing the PK/PD relationships of generic Meropenem (Mercide." Clinical pharmacology : advances and applications vol. 8 (2016): 191-198. doi: https://doi.org/10.2147/CPAA.S106676
Mer M, Snyman JR, van Rensburg CE, van Tonder JJ, Laurens I. A prospective, observational study comparing the PK/PD relationships of generic Meropenem (Mercide. Clin Pharmacol. 2016 Nov 17;8:191-198. doi: 10.2147/CPAA.S106676. eCollection 2016. PMID: 27895516; PMCID: PMC5117905.
Copy Download .nbib Format: NLM
Dapsone as an Immunomodulator In Vivo Using the Tuberculin Skin Test as a Parameter.

Clinical drug investigation

Snyman JR, Jacyk WK, Lizamore DJ, De Sommers K.
PMID: 27519202
Clin Drug Investig. 1995 Sep;10(3):179-82. doi: 10.2165/00044011-199510030-00007.

No abstract available.

Cite
Snyman JR, Jacyk WK, Lizamore DJ, et al. Dapsone as an Immunomodulator In Vivo Using the Tuberculin Skin Test as a Parameter. Clin Drug Investig. 1995;10(3):179-82doi: 10.2165/00044011-199510030-00007.
Snyman, J. R., Jacyk, W. K., Lizamore, D. J., & De Sommers, K. (1995). Dapsone as an Immunomodulator In Vivo Using the Tuberculin Skin Test as a Parameter. Clinical drug investigation, 10(3), 179-82. https://doi.org/10.2165/00044011-199510030-00007
Snyman, J R, et al. "Dapsone as an Immunomodulator In Vivo Using the Tuberculin Skin Test as a Parameter." Clinical drug investigation vol. 10,3 (1995): 179-82. doi: https://doi.org/10.2165/00044011-199510030-00007
Snyman JR, Jacyk WK, Lizamore DJ, De Sommers K. Dapsone as an Immunomodulator In Vivo Using the Tuberculin Skin Test as a Parameter. Clin Drug Investig. 1995 Sep;10(3):179-82. doi: 10.2165/00044011-199510030-00007. PMID: 27519202.
Copy Download .nbib Format: NLM
Vancomycin-resistant enterococcal infections: cause for concern?.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

Snydman DR.
PMID: 14586887
Liver Transpl. 2003 Nov;9(11):1227-8. doi: 10.1002/lt.500091116.

No abstract available.

Cite
Snydman DR. Vancomycin-resistant enterococcal infections: cause for concern?. Liver Transpl. 2003;9(11):1227-8doi: 10.1002/lt.500091116.
Snydman, D. R. (2003). Vancomycin-resistant enterococcal infections: cause for concern?. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 9(11), 1227-8. https://doi.org/10.1002/lt.500091116
Snydman, David R. "Vancomycin-resistant enterococcal infections: cause for concern?." Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society vol. 9,11 (2003): 1227-8. doi: https://doi.org/10.1002/lt.500091116
Snydman DR. Vancomycin-resistant enterococcal infections: cause for concern?. Liver Transpl. 2003 Nov;9(11):1227-8. doi: 10.1002/lt.500091116. PMID: 14586887.
Copy Download .nbib Format: NLM
Correlation of Cytomegalovirus (CMV) Disease Severity and Mortality With CMV Viral Burden in CMV-Seropositive Donor and CMV-Seronegative Solid Organ Transplant Recipients.

Open forum infectious diseases

McBride JM, Sheinson D, Jiang J, Lewin-Koh N, Werner BG, Chow JKL, Wu X, Tavel JA, Snydman DR.
PMID: 30775403
Open Forum Infect Dis. 2019 Jan 14;6(2):ofz003. doi: 10.1093/ofid/ofz003. eCollection 2019 Feb.

BACKGROUND: The rate of cytomegalovirus (CMV) viral load increase and peak viral loads are associated with CMV disease in kidney and liver transplant recipients, but relationships to disease severity or mortality have not been shown.METHODS: Using stored serial serum...

Cite
McBride JM, Sheinson D, Jiang J, et al. Correlation of Cytomegalovirus (CMV) Disease Severity and Mortality With CMV Viral Burden in CMV-Seropositive Donor and CMV-Seronegative Solid Organ Transplant Recipients. Open Forum Infect Dis. 2019;6(2):ofz003doi: 10.1093/ofid/ofz003.
McBride, J. M., Sheinson, D., Jiang, J., Lewin-Koh, N., Werner, B. G., Chow, J. K. L., Wu, X., Tavel, J. A., & Snydman, D. R. (2019). Correlation of Cytomegalovirus (CMV) Disease Severity and Mortality With CMV Viral Burden in CMV-Seropositive Donor and CMV-Seronegative Solid Organ Transplant Recipients. Open forum infectious diseases, 6(2), ofz003. https://doi.org/10.1093/ofid/ofz003
McBride, Jacqueline M, et al. "Correlation of Cytomegalovirus (CMV) Disease Severity and Mortality With CMV Viral Burden in CMV-Seropositive Donor and CMV-Seronegative Solid Organ Transplant Recipients." Open forum infectious diseases vol. 6,2 (2019): ofz003. doi: https://doi.org/10.1093/ofid/ofz003
McBride JM, Sheinson D, Jiang J, Lewin-Koh N, Werner BG, Chow JKL, Wu X, Tavel JA, Snydman DR. Correlation of Cytomegalovirus (CMV) Disease Severity and Mortality With CMV Viral Burden in CMV-Seropositive Donor and CMV-Seronegative Solid Organ Transplant Recipients. Open Forum Infect Dis. 2019 Jan 14;6(2):ofz003. doi: 10.1093/ofid/ofz003. eCollection 2019 Feb. PMID: 30775403; PMCID: PMC6366655.
Copy Download .nbib Format: NLM
Association Between Lymphopenia at 1 Month Posttransplant and Infectious Outcomes or Death in Heart Transplant Recipients.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Perry WA, Paulus JK, Price LL, Snydman DR, Chow JK.
PMID: 33279963
Clin Infect Dis. 2021 Dec 06;73(11):e3797-e3803. doi: 10.1093/cid/ciaa1800.

BACKGROUND: Cell-mediated immunity is a specific target of several medications used to prevent or treat rejection in orthotopic heart transplantation. Low absolute lymphocyte count (ALC) has potential to be a useful and accessible clinical indicator of overall infection risk....

Cite
Perry WA, Paulus JK, Price LL, et al. Association Between Lymphopenia at 1 Month Posttransplant and Infectious Outcomes or Death in Heart Transplant Recipients. Clin Infect Dis. 2021;73(11):e3797-e3803doi: 10.1093/cid/ciaa1800.
Perry, W. A., Paulus, J. K., Price, L. L., Snydman, D. R., & Chow, J. K. (2021). Association Between Lymphopenia at 1 Month Posttransplant and Infectious Outcomes or Death in Heart Transplant Recipients. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 73(11), e3797-e3803. https://doi.org/10.1093/cid/ciaa1800
Perry, Whitney A, et al. "Association Between Lymphopenia at 1 Month Posttransplant and Infectious Outcomes or Death in Heart Transplant Recipients." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America vol. 73,11 (2021): e3797-e3803. doi: https://doi.org/10.1093/cid/ciaa1800
Perry WA, Paulus JK, Price LL, Snydman DR, Chow JK. Association Between Lymphopenia at 1 Month Posttransplant and Infectious Outcomes or Death in Heart Transplant Recipients. Clin Infect Dis. 2021 Dec 06;73(11):e3797-e3803. doi: 10.1093/cid/ciaa1800. PMID: 33279963.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 35 entries